Accessibility Menu
Elixinol Wellness logo

Elixinol Wellness(OTC) ELLXF

Market Cap$3.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)-100%
5 Year-98%
1 Year-65%
1 Month+3%
$0.01
+7.14%
+0.00Today
Elixinol Wellness last closing stock price
MetricPriceDate
Last closeUSD 0.012026-09-04
Elixinol Wellness stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+100%USD 0.002026-08-28
1 month+2.74%USD 0.012026-08-05
3 month+119.51%USD 0.002026-06-05
Year to date+3.45%USD 0.012025-12-31
1 year-65.38%USD 0.032025-08-29
3 year-77.94%USD 0.042023-09-05
5 year-98.48%USD 0.592021-09-03
Since inception-99.91%USD 10.222018-06-05

Elixinol Wellness Financials at a Glance

Market Cap

$3.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$30.93M

Net Income (TTM)

-A$5.54M

EPS (TTM)

-$0.01

P/E Ratio

-1.32

Dividend

$0.00

Beta (Volatility)

-0.45 (Low)

Price

$0.01

Volume

6,037

Open

$0.00

Previous Close

$0.01

Daily Range

$0.00 - $0.01

52-Week Range

$0.00 - $0.03

Estimated Earnings Date

Feb 19, 2027

ELLXF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elixinol Wellness

Elixinol Wellness Limited is an Australian-based company established in 2017, specializing in the production and supply of hemp-derived products. The company offers a diverse range of wellness, beauty, and food items under its well-known brands, Elixinol and Hemp Foods Australia.

Products and Services
  • Comprehensive range of cannabidiol (CBD) products
  • Dietary supplements and various food items
  • Topicals and skincare solutions
Growth Outlook
  • Revenue increased to AUD 7.85 million in Q4 2025
  • Gross profit margin improved to 5.75% in Q4 2025
  • Expansion into significant international markets continues
Financial Highlights
  • Net income of AUD -2.41 million in Q4 2025
  • Operating income ratio of -26.41% in Q4 2025
  • Cash and cash equivalents reached AUD 1.40 million in Q4 2025
Elixinol Wellness Limited operates in the healthcare sector, focusing on the growing demand for hemp-derived products. The company has made significant strides in revenue generation, with a notable increase in Q4 2025, reflecting its potential for growth. Despite facing challenges, such as a negative net income, the company is actively working to improve its financial performance and expand its market presence. The recent improvement in gross profit margin indicates a positive trend in operational efficiency. With a diverse product portfolio and a commitment to quality, Elixinol Wellness Limited is positioned to capitalize on the expanding global market for hemp-based wellness products.
AI Generated • Aug 29, 2026

Industry

Personal Products

Sector

Consumer Staples

CEO

Natalie Butler

Website

www.elixinolglobal.com

Headquarters

Newtown, VIC 3220, AU

ELLXF Financials

Key Financial Metrics (TTM)

Gross Margin

11.03%

Operating Margin

-17.81%

Net Income Margin

-23.10%

Return on Equity

-50.35%

Return on Capital

-44.51%

Return on Assets

-22.93%

Earnings Yield

-75.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

438.20M

Volume

6.04K

Avg. Volume

1.70K

Financials (TTM)

Gross Profit

A$7.54M

Operating Income

-A$8.19M

EBITDA

-A$6.95M

Operating Cash Flow

-A$5.25M

Capital Expenditure

-A$101.08K

Free Cash Flow

-A$5.35M

Cash & ST Invst.

A$994.60K

Total Debt

A$4.03M

Elixinol Wellness Performance Analysis

Elixinol Wellness annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31AUD 4,890,748-30.2%
20232023-12-31AUD 5,488,68312.2%
20242024-12-31AUD 9,864,96379.7%
20252025-12-31AUD 9,994,6151.3%
Elixinol Wellness sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3120.9%
Q22025-06-30-6.3%
Q42025-12-312.5%
Q22026-06-30-7.9%
Elixinol Wellness annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31AUD -0.14-42.9%
20232023-12-31AUD -0.07-54.6%
20242024-12-31AUD -0.01-88.9%
20252025-12-31AUD -0.0189.0%
Elixinol Wellness sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31300.0%
Q22025-06-30-348.2%
Q42025-12-3146.0%
Q22026-06-3065.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$7.23M

+6.8%

Gross Profit

A$1.21M

-49.7%

Gross Margin

16.80%

N/A

Market Cap

$3.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$51.89K

N/A

Employees

76

N/A

Net Income

-A$1.08M

+61.0%

EBITDA

-A$234.10K

+89.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$994.60K

-36.9%

Total Debt

A$4.03M

+240.6%

Accounts Receivable

A$1.60M

-20.2%

Inventory

A$2.25M

-44.7%

Long Term Debt

A$271.62K

+68.7%

Short Term Debt

A$3.75M

+267.7%

Return on Assets

-22.93%

N/A

Return on Invested Capital

-32.72%

N/A

Free Cash Flow

-A$736.45K

+66.4%

Operating Cash Flow

-A$715.35K

+66.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PHCGPure Harvest Corporate Group, Inc.
$0.02-6.84%
NPHCNutra Pharma Corp.
$0.00+0.00%
PAIOFPaion AG
$0.07+0.00%
CSUICannabis Suisse Corp.
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About ELLXF

What is the current price of Elixinol Wellness?

Elixinol Wellness is trading at $0.01 per share.

What is the 52-week range for Elixinol Wellness?

Over the past 52 weeks, Elixinol Wellness has traded between $0.00 and $0.03.

How much debt does Elixinol Wellness have?

As of the most recent reporting period, Elixinol Wellness reported total debt of A$2.49M.

How much cash does Elixinol Wellness have on hand?

Elixinol Wellness reported A$936.92K in cash and cash equivalents in its most recent financial results.

What is Elixinol Wellness’s dividend yield?

Elixinol Wellness does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services